Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, January 6, 2023
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
Thu, January 5, 2023
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
Tony Butler Initiated (BCYC) at Strong Buy and Held Target at $55 on, Jan 5th, 2023
Tony Butler of EF Hutton, Initiated "Bicycle Therapeutics plc" (BCYC) at Strong Buy and Held Target at $55 on, Jan 5th, 2023.
Tony has made no other calls on BCYC in the last 4 months.
There are 2 other peers that have a rating on BCYC. Out of the 2 peers that are also analyzing BCYC, 1 agrees with Tony's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Jeffrey Hung of "Morgan Stanley" Maintained at Hold with Decreased Target to $45 on, Monday, September 12th, 2022
This is the rating of the analyst that currently disagrees with Tony
- Reni Benjamin of "JMP Securities" Maintained at Buy with Decreased Target to $46 on, Wednesday, November 9th, 2022
